Nautilus Biotechnology, Inc.NAUTNASDAQ
LOADING
|||
Analyst Sentiment
Analysts are neutral — opinion is divided on direction.
Consensus Rating
Hold
4 analysts·Low coverage
50%
Rating Distribution
Strong Buy
00%
Buy
250%
Hold
125%
Sell
125%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Analysts see moderate upside — consensus target 28% higher.
Bear Case
$2.50
+28%
Consensus
$2.50
+28%
Bull Case
$2.50
+28%
Price Range4 analysts
Low
Consensus
High
$2.50
$2.50
Current Target
Current Price
$1.95
Upside to Target
$0.55
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.